» Articles » PMID: 29935278

Social Approach, Anxiety, and Altered Tryptophan Hydroxylase 2 Activity in Juvenile BALB/c and C57BL/6J Mice

Overview
Journal Behav Brain Res
Date 2018 Jun 24
PMID 29935278
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorder (ASD) is a heterogeneous and highly heritable condition with multiple aetiologies. Although the biological mechanisms underlying ASD are not fully understood, evidence suggests that dysregulation of serotonergic systems play an important role in ASD psychopathology. Preclinical models using mice with altered serotonergic neurotransmission may provide insight into the role of serotonin in behaviours relevant to clinical features of ASD. For example, BALB/c mice carry a loss-of-function single nucleotide polymorphism (SNP; C1473 G) in tryptophan hydroxylase 2 (Tph2), which encodes the brain-specific isoform of the rate-limiting enzyme for serotonin synthesis, and these mice frequently have been used to model symptoms of ASD. In this study, juvenile male BALB/c (G/G; loss-of-function variant) and C57BL/6 J (C/C; wild type variant) mice, were exposed to the three-chamber sociability test, and one week later to the elevated plus-maze (EPM). Tryptophan hydroxylase 2 (TPH2) activity was measured following injection of the aromatic amino acid decarboxylase (AADC)-inhibitor, NSD-1015, and subsequent HPLC detection of 5-hydroxytryptophan (5-HTP) within subregions of the dorsal raphe nucleus (DR) and median raphe nucleus (MnR). The BALB/c mice showed reduced social behaviour and increased anxious behaviour, as well as decreased 5-HTP accumulation in the rostral and mid-rostrocaudal DR. In the full cohort of mice, TPH2 activity in the mid-rostrocaudal DR was correlated with anxious behaviour in the EPM, however these correlations were not statistically significant within each strain, suggesting that TPH2 activity was not directly associated with either anxiety or sociability. Further research is therefore required to more fully understand how serotonergic systems are involved in mouse behaviours that resemble some of the clinical features of ASD.

Citing Articles

Exploring the Missing link between vitamin D and autism spectrum disorder: Scientific evidence and new perspectives.

Gao T, Dang W, Jiang Z, Jiang Y Heliyon. 2024; 10(17):e36572.

PMID: 39281535 PMC: 11401093. DOI: 10.1016/j.heliyon.2024.e36572.


Pre-pregnancy stress induces maternal vascular dysfunction during pregnancy and postpartum.

ODonnell M, Stumpp L, Gallaher M, Powers R Reprod Sci. 2023; 30(11):3197-3211.

PMID: 37219786 PMC: 10204668. DOI: 10.1007/s43032-023-01248-2.


Early life adversity: Epigenetic regulation underlying drug addiction susceptibility.

Winter J, Rodriguez-Acevedo K, Dittrich M, Heller E Mol Cell Neurosci. 2023; 125:103825.

PMID: 36842544 PMC: 10247461. DOI: 10.1016/j.mcn.2023.103825.


A Systematic Review of Brainstem Contributions to Autism Spectrum Disorder.

Seif A, Shea C, Schmid S, Stevenson R Front Integr Neurosci. 2021; 15:760116.

PMID: 34790102 PMC: 8591260. DOI: 10.3389/fnint.2021.760116.


Gut instincts: vitamin D/vitamin D receptor and microbiome in neurodevelopment disorders.

Ogbu D, Xia E, Sun J Open Biol. 2020; 10(7):200063.

PMID: 32634371 PMC: 7574554. DOI: 10.1098/rsob.200063.